Ebenbuild
Healthcare Software · Germany · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Holzstr. 28, Munich, Bavaria, 80469, Ger...Phone Number
+49 8921525477Website
www.ebenbuild.comRevenue
<$5 MillionIndustry
About Ebenbuild
Is Ebenbuild your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Ebenbuild had a recent Job posting/layoffs
Funding: Get notified immidiatlly once Ebenbuild has new funding data
Check if Ebenbuild has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Ebenbuild recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Ebenbuild
Ebenbuild, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check out if Ebenbuild is spiking on competitors!
Product Launch: Get notified when Ebenbuild launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Reach out to Masked Content who joined Ebenbuild as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Ebenbuild is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Ebenbuild is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Ebenbuild.
Ebenbuild Tech Stack
A closer look at the technologies used by Ebenbuild
Ebenbuild News & Media
Ebenbuild Contributes Cutting-Edge Digital Lung Simulations to Pulmonary Fibrosis Drug Development
Munich, Germany – April 9, 2025 -- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced its contribution to a pioneering study published today in Nature Communications. The article titled Preclinical concept studies showing advantage of an inhaled anti-CTGF/CCN2 protein for pulmonary fibrosis treatment (DOI:10.1038/s41467-025-58568-x) highlights the potential of inhaled therapeutics for treatingEbenbuild Appoints Charles A. Taylor, PhD as Chairman of the Board
Munich, Germany, November 11, 2024 -- Ebenbuild, a company developing personalized, AI-enabled digital twins of lungs to support clinical decisions and digital clinical trials, today announced that Charles A. Taylor, PhD has been appointed Chairman of the Board. Dr. Taylor is a pioneer in the field of predictive, simulation-based medicine where he applied computational fluid dynamics to predict outcomes of cardiovascular interventions in individual patients.Ebenbuild to Receive Public Funding Under UBIC Consortium for Digital Lung Twin Project
Munich, Germany, November 28, 2023 -- Ebenbuild, a company developing personalized, AI-driven virtual lungs to support clinical decisions and digital clinical trials, today announced its participation in the research project Personalized Lung Twins for the Treatment of Acute Respiratory Distress Syndrome (UBIC) in collaboration with the University Hospital Schleswig-Holstein, Augsburg University Hospital, University Hospital Carl Gustav Carus Dresden, University Hospital RWTH Aachen and Universi
Top Healthcare Software Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Ebenbuild
Ebenbuild specializes in precision therapy through personalized digital twins, focusing on pulmonary care. Their innovative technology combines advanced physics-based modeling with patient-specific data to create virtual replicas of individual lungs, enabling clinicians to simulate ventilation strategies and optimize drug delivery. The company's ap... Read More